Your new post is loading...
A new study in the New England Journal of Medicine documents the high-profile failure of a promising drug, bapineuzumab, to slow cognitive decline in dementia patients. Dr.
Via Krishan Maggon
|
Scooped by Gilbert C FAURE from Alzheimer's Disease R&D Review |
Scoop.it!
Via Krishan Maggon
No comment yet.
Sign up to comment
